Heart Disease Trial, Recruiting NCT00181259 Sponsor: Johns Hopkins University Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT00181259
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are older than 18 years of age
  • Healthy volunteers: people with no history of heart disease
  • People with dilated cardiomyopathy: a history of heart failure and a weakened heart that pumps less than 40% of its blood with each beat
  • People with left ventricular hypertrophy: a thickened heart wall measuring more than 1.2cm
  • People with coronary artery disease: a blockage of more than 50% in a heart artery, or a stress test that showed a problem with blood flow to the heart

Who may not be able to join:

  • People for whom an MRI scan is not safe or suitable (for example, those with certain metal implants or devices — confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Robert G. Weiss, MD, Johns Hopkins University

Phone: 410-955-1703

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 January 1988
Est. completion
1 August 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Phosphocreatine/adenosine triphosphate (PCr/ATP) and creatine kinase (CK) flux

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov